Tri Tran

Title: The Innovative Contributions of Tri Tran

Introduction

Tri Tran is a notable inventor based in Sacramento, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that can aid in cancer treatment. His work exemplifies the intersection of innovation and healthcare, showcasing how inventions can lead to improved therapeutic options.

Latest Patents

Tri Tran holds a patent for his invention titled "Crystalline Forms on N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide." This invention relates to three crystalline forms of a compound designated as Form A, Form B, and Form C. The invention provides methods for the treatment of cancer by exploiting the modulation of protein kinase activity. Additionally, it includes pharmaceutical compositions containing a crystalline form of the compound and a pharmaceutically acceptable excipient.

Career Highlights

Tri Tran is currently employed at Exelixis, Inc., a company known for its focus on developing innovative cancer therapies. His role at Exelixis allows him to contribute to groundbreaking research and development in the pharmaceutical industry. His patent reflects his commitment to advancing medical science and improving patient outcomes.

Collaborations

Tri Tran has collaborated with notable colleagues, including Hilary Cannon and David Igo. These partnerships highlight the collaborative nature of research and innovation in the pharmaceutical field.

Conclusion

Tri Tran's contributions to the field of pharmaceuticals through his innovative patent demonstrate the vital role of inventors in advancing healthcare solutions. His work not only showcases his expertise but also emphasizes the importance of collaboration in achieving significant breakthroughs.